Immortality Drug is still a mysterious and attractive subjec
Immortality Drug is still a mysterious and attractive subject for both science and philosophy. So far, no such medicine has been made scientifically which can provide complete immortality to humans. But research continues in some areas that are trying to prolong life or slow down the process of aging.
1. Scientific research on age growth and immortality Currently, things that are being researched can be considered a step in the direction of immortality:
❖ Telomerase Enzyme and Genetic Engineering • The age of the cells depends on the telomers, which become smaller on the division each time.
• Scientists are trying to lengthen telomers by activating telomeres enzymes, so that age can be increased.
❖ Senolytics
• These drugs eliminate aged and damaged cells so that healthy cells can work better. ❖ Cryonics
• Some people are freezing their body at -196 ° C after death, in the hope that when the technology of immortality comes in future, they can be revived.
❖ nad boosters (eg NMN, NR)
• NAD is a coonzyme that helps in mitochondria's health and DNA repair.
• To increase this, research is being done on medicines and supplements (such as NMN). ,
2. Ayurveda and immortality There is also a description of immortality in Indian tradition, such as:
• Sanjeevani Booti: Who can also make the dead person alive (mentioned in Ramayana).
• Chemistry: Some medicines in Ayurveda are considered to keep the body longevity and disease free - such as Chyawanprash, Ashwagandha, Brahmi, Shilajit etc. ,
3. Truth currently
• No medicine has been provided with immortality till now.
• But some remedies and lifestyle changes can increase age:
• Balanced diet
• regular exercise
• Freedom from mental stress
• social bonding
• Sleep and meditation , If you want, I can give you a list of some current laboratories or researchers who are working on immortality or age, such as:
• Dr. David Sinclair (harvard)
• Altos Labs (Amazon's Jeff Bezos funded)
• Calico (supported by Google)
Comments
No comments yet.